Aurobindo Pharma Limited’s shares fell on Friday, snapping a three-day winning streak following the report that the US Food and Drug Administration (USFDA) had issued a warning notice to its subsidiary’s manufacturing facility. On Friday, Aurobindo Pharma shares fell to an intraday low of Rs 1,426.80 a share on the National Stock Exchange. The pharmaceutical ...